Equities

Advides AG

4RL:BER

Advides AG

Actions
  • Price (EUR)0.134
  • Today's Change0.00 / 0.00%
  • Shares traded2.20k
  • 1 Year change-52.98%
  • Beta0.6648
Data delayed at least 15 minutes, as of Nov 07 2024 07:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

advides AG is a Germany-based company that is engaged in the financial sector. The Company focuses its activities on the corporate finance, private equity, as well as investments and trading business areas. In the field of corporate finance, it concentrates on the provision of consulting services to companies that plan initial public offerings (IPOs). advides AG is active worldwide and invests in listed and unlisted companies. The Company also trades for its own account in shares, bonds, derivatives, currencies and commodities. In the area of consulting, advides AG’s focus is on IPO and restructuring projects. It offers consulting solutions for institutional and private investors.

  • Revenue in EUR (TTM)2.15m
  • Net income in EUR316.00k
  • Incorporated2003
  • Employees1.00
  • Location
    Advides AGTeltower Damm 283BERLIN 14167GermanyDEU
  • Phone+49 3 045953430
  • Fax+49 3 045953432
  • Websitehttps://www.advides.de/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Syrakus Holding AG-100.00bn-100.00bn121.24k0.00--------------------------12.86--15.31--99.93--10.47--------22.9818.86-173.38------
Finchain Capital Partners AG-100.00bn-100.00bn189.00k----------------0.00-----------46.01---47.26-------8,445.3514.52--0.00------99.07------
advides AG2.15m316.00k210.43k1.000.38670.27220.60820.0980.34650.34652.350.4923----------------35.48--14.73------0.00---98.98--80.16------
Auden AG0.00-1.18m227.24k----0.1019-----1.33-1.330.002.450.00-------17.87-16.15-28.34-52.91----------1.280.00-------73.79------
Averdion Se-100.00bn-100.00bn254.71k--------------------------------------------------------------
Konsortium AG-99.00k-4.05m255.91k0.00---------3.14-3.14-0.0769------------1.76--1.77------44.73------0.002.02-14.4630.41------
Dessixx AG0.00-14.79k280.18k----1.53-----0.0592-0.05920.000.71680.00-------7.74---7.74--------------0.00------9.49------
Hbi-Hyperion Se0.00-40.93k458.47k-----------0.1091-0.10910.000.000.00-------29.85-56.28-253.83-68.06-------2,376.04----0.00--110.00--93.10------
The New Meat Company AG51.72k-272.52k505.32k1.00--0.1198--9.77-0.0959-0.09590.01771.250.0144--0.35251,720.00-7.60---8.41-------526.91------0.00------5.95------
aXendis Capital SE0.00-2.61m529.79k1.00--0.49163.03---2.00-2.000.000.81370.00----0.00-102.25---104.47--------------0.00-------234.26------
Commertunity AG490.00k-1.95m570.55k2.00--114.99--1.16-0.9756-0.97560.2450.00242.31----245,000.00-920.86---1,850.24--57.14---398.20-----0.16240.00-------4,337.50------
Data as of Nov 07 2024. Currency figures normalised to Advides AG's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.